{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:06:19Z","timestamp":1777359979243,"version":"3.51.4"},"reference-count":33,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Objective.<\/jats:bold>\n                    Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver diseases characterized by the presence of ectopic fat in the liver and steatosis, which cannot be explained by alcohol consumption. The association between NAFLD and type 2 diabetes mellitus (T2DM) is well established. As liver fibrosis progresses in a patient with NAFLD, insulin resistance (IR) increases and may worsen diabetes control. The aspartate aminotransferase platelet ratio index (APRI) score is a simple and inexpensive bedside marker that can detect liver fibrosis and cirrhosis. Several studies have shown an association between APRI and NAFLD. However, there is a gap in correlation with IR in patients with diabetes. In this study, we sought to correlate IR and NAFLD in diabetes using the APRI score.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods.<\/jats:bold>\n                    This observational hospital-based cross-sectional study was conducted in the Department of General Medicine, one of the tertiary care hospitals in North India, from February 2019 to July 2020. A total of 70 patients were taken for the study. Patients with T2DM, aged &gt;30 years, who had no history of alcohol use and who had or were newly diagnosed with NAFLD were enrolled in the study.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.<\/jats:bold>\n                    Significant differences in mean HbAc1, AST, serum insulin, APRI score and homeo-static model assessment-2 (HOMA2) IR between NAFLD grade 1, grade 2, and grade 3 groups were found. Pearson correlation between APRI score and HOMA2 IR total values revealed a significant positive correlation between them.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions.<\/jats:bold>\n                    The data of the present study indicate that the APRI score can be used to assess the IR degree and provide important information for improving glycemic control in T2DM patients with NAFLD.\n                  <\/jats:p>","DOI":"10.2478\/enr-2023-0013","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T15:38:19Z","timestamp":1686152299000},"page":"106-113","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of aspartate aminotransferase platelet ratio index score and insulin resistance in type 2 diabetes mellitus with non-alcoholic fatty liver disease"],"prefix":"10.2478","volume":"57","author":[{"given":"Nikhil","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Medicine , School of Medical Science & Research, Sharda University , UP , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waseem","family":"Ramzaan Dar","sequence":"additional","affiliation":[{"name":"Department of Medicine , School of Medical Science & Research, Sharda University , UP , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Wani","sequence":"additional","affiliation":[{"name":"Department of Medicine , School of Medical Science & Research, Sharda University , UP , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachit","family":"Raj Saxena","sequence":"additional","affiliation":[{"name":"Department of Medicine , School of Medical Science & Research, Sharda University , UP , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahil","family":"Khatri","sequence":"additional","affiliation":[{"name":"Department of Medicine , School of Medical Science & Research, Sharda University , UP , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhumesh","family":"Tyagi","sequence":"additional","affiliation":[{"name":"Department of Medicine , School of Medical Science & Research, Sharda University , UP , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Bansal","sequence":"additional","affiliation":[{"name":"Department of Medicine , School of Medical Science & Research, Sharda University , UP , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irfan","family":"Ahmad Mir","sequence":"additional","affiliation":[{"name":"Department of Medicine , School of Medical Science & Research, Sharda University , UP , India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"2026042723194363569_j_enr-2023-0013_ref_001","doi-asserted-by":"crossref","unstructured":"Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, Weksler B, Esteban R. Thrombocytopenia associated with chronic liver disease. J Hepatol 48, 1000\u20131007, 2008.","DOI":"10.1016\/j.jhep.2008.03.009"},{"key":"2026042723194363569_j_enr-2023-0013_ref_002","doi-asserted-by":"crossref","unstructured":"Aller R, de Luis, DA, Fernandez L. Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease. Dig Dis Sci 53, 1088\u20131092, 2008.","DOI":"10.1007\/s10620-007-9981-3"},{"key":"2026042723194363569_j_enr-2023-0013_ref_003","unstructured":"American Diabetes Association. Diabetes Care 43, S14\u2013S31, 2020."},{"key":"2026042723194363569_j_enr-2023-0013_ref_004","doi-asserted-by":"crossref","unstructured":"Bae JC, Cho YK, Lee WY, Seo H, Rhee EJ. Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects. Am J Gastroenterol 105, 2389\u20132395, 2010.","DOI":"10.1038\/ajg.2010.275"},{"key":"2026042723194363569_j_enr-2023-0013_ref_005","doi-asserted-by":"crossref","unstructured":"Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387\u20131395, 2004.","DOI":"10.1002\/hep.20466"},{"key":"2026042723194363569_j_enr-2023-0013_ref_006","doi-asserted-by":"crossref","unstructured":"Das S, Singh SP, Parida PK, Mallik RN. Non-alcoholic fatty liver disease in subjects with type 2 diabetes mellitus and non-diabetics with special reference to insulin resistance and hepatic histopathological changes. Clin Res Rev 4, 226\u2013229, 2010.","DOI":"10.1016\/j.dsx.2010.07.004"},{"key":"2026042723194363569_j_enr-2023-0013_ref_007","doi-asserted-by":"crossref","unstructured":"Forlani G, Giorda C, Manti R, Mazzella N, De Cosmo S, Rossi MC, Nicolucci A, Di Bartolo P, Ceriello A, Guida P; AMD-Annals Study Group. The burden of NAFLD and its characteristics in a nationwide population with type 2 diabetes. J Diabetes Res 2016, 2931985, 2016.","DOI":"10.1155\/2016\/2931985"},{"key":"2026042723194363569_j_enr-2023-0013_ref_008","doi-asserted-by":"crossref","unstructured":"Garjani A, Safaeiyan A, Khoshbaten M. Association between platelet count as a noninvasive marker and ultrasono-graphic grading in patients with nonalcoholic fatty liver disease. Hepat Mon 15, e24449, 2015.","DOI":"10.5812\/hepatmon.24449"},{"key":"2026042723194363569_j_enr-2023-0013_ref_009","doi-asserted-by":"crossref","unstructured":"Ghamar-Chehreh ME, Khedmat H, Amini M, Taheri S. Predictive factors for ultrasonographic grading of nonalcoholic fatty liver disease. Hepat Mon 12, e6860, 2012.","DOI":"10.5812\/hepatmon.6860"},{"key":"2026042723194363569_j_enr-2023-0013_ref_010","doi-asserted-by":"crossref","unstructured":"Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, Wasada T. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 22, 1141\u20131145, 2005.","DOI":"10.1111\/j.1464-5491.2005.01582.x"},{"key":"2026042723194363569_j_enr-2023-0013_ref_011","doi-asserted-by":"crossref","unstructured":"Jung CH, Lee B, Choi DH, Jung SH, Kim BY. Association of the grade of non-alcoholic fatty liver disease and glycated albumin to glycated haemoglobin ratio in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 125, 53\u201361, 2016.","DOI":"10.1016\/j.diabres.2016.12.017"},{"key":"2026042723194363569_j_enr-2023-0013_ref_012","doi-asserted-by":"crossref","unstructured":"Junior WS, Nonino-Borges CB. Clinical predictors of different grades of nonalcoholic fatty liver disease. Obes Surg 22, 248\u2013252, 2012.","DOI":"10.1007\/s11695-011-0438-6"},{"key":"2026042723194363569_j_enr-2023-0013_ref_013","unstructured":"Kalra S, Vithalani M, Gulati G. Study of the prevalence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). J Assoc Physicians India 61, 448\u2013453, 2013."},{"key":"2026042723194363569_j_enr-2023-0013_ref_014","unstructured":"Kruger FC, Daniels CR, Kidd M, Swart G, Brundyn K, van Rensburg C, Kotze M. APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD\/NASH. S Afr Med J 101, 477\u2013480, 2011."},{"key":"2026042723194363569_j_enr-2023-0013_ref_015","doi-asserted-by":"crossref","unstructured":"Lee J, Vali Y, Boursier J, Spijker R, Anstee QM, Bossuyt PM, Zafarmand MH. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review. Liver Int 41, 261\u2013270, 2021.","DOI":"10.1111\/liv.14669"},{"key":"2026042723194363569_j_enr-2023-0013_ref_016","doi-asserted-by":"crossref","unstructured":"Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ. Performance of the aspartate aminotransferase\u2010to\u2010platelet ratio index for the staging of hepatitis C\u2010related fibrosis: An updated meta\u2010analysis. Hepatology 53, 726\u2013736, 2011.","DOI":"10.1002\/hep.24105"},{"key":"2026042723194363569_j_enr-2023-0013_ref_017","doi-asserted-by":"crossref","unstructured":"Lopez-Velazquez JA, Silva-Vidal KV, Ponciano-Rodriguez G, Chavez-Tapia NC. The prevalence of non-alcoholic fatty liver disease in the Americas. Ann Hepatol 13, 166\u2013178, 2014.","DOI":"10.1016\/S1665-2681(19)30879-8"},{"key":"2026042723194363569_j_enr-2023-0013_ref_018","doi-asserted-by":"crossref","unstructured":"Machado MV, Cortez-Pinto H. Non-alcoholic fatty liver disease: what the clinician needs to know. World J Gastroenterol 20, 12956\u201312980, 2014.","DOI":"10.3748\/wjg.v20.i36.12956"},{"key":"2026042723194363569_j_enr-2023-0013_ref_019","doi-asserted-by":"crossref","unstructured":"Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, Bass NM. Correlation of paired liver biopsies in morbidly obese patients with suspected non-alcoholic fatty liver disease. Hepatology 44, 874\u2013880, 2006.","DOI":"10.1002\/hep.21346"},{"key":"2026042723194363569_j_enr-2023-0013_ref_020","doi-asserted-by":"crossref","unstructured":"Muzurovic E, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism 119, 154770, 2021.","DOI":"10.1016\/j.metabol.2021.154770"},{"key":"2026042723194363569_j_enr-2023-0013_ref_021","doi-asserted-by":"crossref","unstructured":"Muzurovic E, Peng CC, Belanger MJ, Sanoudou D, Mikhailidis DP, Mantzoros CS. Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors. Hypertension 79, 1319\u20131326, 2022.","DOI":"10.1161\/HYPERTENSIONAHA.122.17982"},{"key":"2026042723194363569_j_enr-2023-0013_ref_022","doi-asserted-by":"crossref","unstructured":"Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD\/NASH based on the EASL 2009 special conference. J Hepatol 53, 372\u2013384, 2010.","DOI":"10.1016\/j.jhep.2010.04.008"},{"key":"2026042723194363569_j_enr-2023-0013_ref_023","doi-asserted-by":"crossref","unstructured":"Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M. The utility of radiological imaging in non-alcoholic fatty liver disease. Gastroenterology 123, 745\u2013750, 2002.","DOI":"10.1053\/gast.2002.35354"},{"key":"2026042723194363569_j_enr-2023-0013_ref_024","doi-asserted-by":"crossref","unstructured":"Sapmaz F, Uzman M, Basyigit S. Steatosis grade is the most important risk factor for development of endothelial dysfunction in NAFLD. Medicine (Baltimore) 95, e3280, 2016.","DOI":"10.1097\/MD.0000000000003280"},{"key":"2026042723194363569_j_enr-2023-0013_ref_025","doi-asserted-by":"crossref","unstructured":"Saremi Z, Rastgoo M, Mohammadifard M, Bijari B, Akbari E. Comparison of platelet number and function between nonalcoholic fatty liver disease and normal individuals. J Res Med Sci 22, 75, 2017.","DOI":"10.4103\/jrms.JRMS_711_16"},{"key":"2026042723194363569_j_enr-2023-0013_ref_026","doi-asserted-by":"crossref","unstructured":"Shah NADM, Kadla SA, Mir IA, Khan BA, Shah AI, Shiekh SA, Bhat KJ. Diagnostic accuracy of FIB-4, APRI, AST\/ALT ratio for prediction of fibrosis in chronic hepatitis B and C patients. Nigerian Journal of Gastroenterology and Hepatology 9, 55\u201261, 2017.","DOI":"10.1016\/j.jceh.2017.05.045"},{"key":"2026042723194363569_j_enr-2023-0013_ref_027","doi-asserted-by":"crossref","unstructured":"Smith BW, Adams LA. Non-alcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol 7, 456\u2013465, 2011.","DOI":"10.1038\/nrendo.2011.72"},{"key":"2026042723194363569_j_enr-2023-0013_ref_028","doi-asserted-by":"crossref","unstructured":"Suzuki A, Angulo P, Lymp J, St Sauver J, Muto A, Okada T, Lindor K. Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology 41, 64\u201371, 2005.","DOI":"10.1002\/hep.20543"},{"key":"2026042723194363569_j_enr-2023-0013_ref_029","unstructured":"The University of Oxford. Diabetes trails unit. The Oxford centre of diabetes, Endocrinology and Metabolism https:\/\/www.dtu.ox.ac.uk\/homacalculator\/"},{"key":"2026042723194363569_j_enr-2023-0013_ref_030","doi-asserted-by":"crossref","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38, 518\u2013526, 2003.","DOI":"10.1053\/jhep.2003.50346"},{"key":"2026042723194363569_j_enr-2023-0013_ref_031","doi-asserted-by":"crossref","unstructured":"Xian YX, Weng JP, Xu F. MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy. Chin Med J (Engl) 134, 8\u201319, 2020.","DOI":"10.1097\/CM9.0000000000001263"},{"key":"2026042723194363569_j_enr-2023-0013_ref_032","unstructured":"Yilmaz Y, Yonal O, Kurt R, Bayrak M, Aktas B, Ozdogan O. Non-invasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease. Hepat Mon 11, 103\u2013106, 2011."},{"key":"2026042723194363569_j_enr-2023-0013_ref_033","doi-asserted-by":"crossref","unstructured":"Yoneda M, Fujii H, Sumida Y. Platelet count for predicting fibrosis in nonalcoholic fatty liver disease. J Gastroenterol 46, 1300\u20131306, 2011.","DOI":"10.1007\/s00535-011-0436-4"}],"container-title":["Endocrine Regulations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/enr-2023-0013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:29:19Z","timestamp":1777357759000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/enr-2023-0013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,6,7]]},"published-print":{"date-parts":[[2023,1,1]]}},"alternative-id":["10.2478\/enr-2023-0013"],"URL":"https:\/\/doi.org\/10.2478\/enr-2023-0013","relation":{},"ISSN":["1336-0329"],"issn-type":[{"value":"1336-0329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,1]]}}}